Target intelligence / Profile preview

ETHE1 persulfide dioxygenase (ETHE1)

Target
ETHE1
Molecular classification
Enzyme, Sulfur dioxygenase, Mono-iron oxygenase, Member of metallo-β-lactamase (MBL) fold superfamily
01

Overview

ETHE1 persulfide dioxygenase is a mitochondrial enzyme encoded by the ETHE1 gene on chromosome 19, principally functioning as a sulfur dioxygenase. It catalyzes the oxygen-dependent oxidation of glutathione persulfide to glutathione and persulfite, protecting cells from hydrogen sulfide toxicity and ensuring mitochondrial energy production. ETHE1 is particularly active in the gastrointestinal tract, but also in the liver and thyroid, and is essential for cellular bioenergetics and redox balance. Mutations in the ETHE1 gene lead to ethylmalonic encephalopathy, a devastating early-onset multisystem disease characterized by neurological degeneration, vascular pathology, and chronic diarrhea. The enzyme is a non-heme iron-dependent oxygenase, structurally belonging to the metallo-β-lactamase superfamily, and features a specialized active site coordinating iron and facilitating substrate turnover. Beyond rare genetic disorders, altered expression has been noted in some cancers, suggesting broader metabolic and biomarker significance.

Other names
Ethylmalonic encephalopathy protein 1Sulfur dioxygenase ETHE1SDOProtein ETHE1, mitochondrialETHE1 gene/protein
02

Mechanism of action

For hypothetical or experimental inhibitors, likely inhibition of sulfur dioxygenase activity to modulate H₂S metabolism or related redox signaling

03

Biological functions

Hydrogen sulfide catabolismSulfur metabolismCatalysis of glutathione persulfide oxidationMitochondrial energy and redox homeostasisProtection of cytochrome c oxidase and other iron-dependent enzymes from sulfide inhibition
04

Disease associations

Ethylmalonic encephalopathy (rare genetic disorder)Leigh syndrome (reported/possible association)Cardiovascular disease (proposed)Cancer (expression altered in some cancers; metabolic implications suggested)
05

Safety considerations

Disruption of ETHE1 activity leads to buildup of toxic sulfide, suffocation of cellular respiration, multi-system damage, and early-onset fatal encephalopathy.Therapeutic modulation would need to consider central energy metabolism and redox balance
06

Biomarkers

Mutations in ETHE1 gene used for diagnosis of ethylmalonic encephalopathyNo established routine biomarkers for therapeutic monitoring

Beyond the preview

Go deeper on ETHE1 persulfide dioxygenase (ETHE1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ETHE1 persulfide dioxygenase (ETHE1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call